The c-Mos proto-oncogene product plays an essential role during meiotic div
isions in vertebrate eggs. In Xenopus, it is required for progression of oo
cyte maturation and meiotic arrest of unfertilized eggs. Its degradation af
ter fertilization is essential to early embryogenesis. In this study we inv
estigated the mechanisms involved in c-Mos degradation. We present in vivo
evidence for ubiquitin-dependent degradation of c-Mos in activated eggs. We
found that c-Mos degradation is not directly dependent on the anaphase-pro
moting factor activator Fizzy/cdc20 but requires cyclin degradation. We dem
onstrate that cyclin B/cdc2 controls in vivo c-Mos phosphorylation and stab
ilization. Moreover, we show that cyclin B/cdc2 is capable of directly phos
phorylating c-Mos in vitro, inducing a similar mobility shift to the one ob
served in vivo. Tryptic phosphopeptide analysis revealed a practically iden
tical in vivo and in vitro phosphopeptide map and allowed identification of
serine-3 as the largely preferential phosphorylation site as previously de
scribed (Freeman et al., 1992). Altogether, these results demonstrate that,
in vivo, stability of c-Mos is directly regulated by cyclin B/cdc2 kinase
activity.